Saturday, March 20, 2010: 12:30 PM-2:00 PM
Grand Hall (Hyatt Regency Atlanta)
Poster
504
Systematic Review of Measurement and Adjustment for Colonization Pressure in Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant enterococci (VRE)
Adebola Ajao, MPH, University of Maryland;
Anthony Harris, MD, MPH, University of Maryland School of Medicine;
Mary-Claire Roghmann, MD, MS, University of Maryland and VA Maryland Health Care System;
J. Kristie Johnson, PhD, University of Maryland;
Min Zhan, PhD, University of Maryland;
Jessina C. McGregor, PhD, Oregon State University College of Pharmacy;
Jon Furuno, PhD, University of Maryland
505
Development of a Novel, Multi-facility Electronic Interface for the Exchange of MRSA Surveillance Data
Lisa Hines, RN, CIC, The Ohio State University Medical Center;
David Newman, BBA, The Ohio State University Medical Center;
Jennifer Santangelo, BA, The Ohio State University Medical Center;
Shu-Hua Wang, MD, MPH, The Ohio State University Medical Center;
Yosef Khan, MBBS, MPH, The Ohio State University Medical Center;
Kurt Stevenson, MD, MPH, The Ohio State University Medical Center
506
The structure of causal attribution in Healthcare-Associated Infections: A Network Analysis
Chukwuemeka Linus Nwaneri, MBBS, MSc, Trinity College, University of Dublin;
Malcolm MacLachlan, PhD, Trinity College, University of Dublin;
Amy Brogan, Trinity College, University of Dublin;
David Hevey, PhD, Trinity College, University of Dublin
508
The Changing Epidemiology of Methicillin-resistant Staphylococcus aureus (MRSA) over 3 years in an Acute Hospital
Eilish Creamer, MSc, Royal College of Surgeons in Ireland;
Anthony Dolan, BSc, Royal College of Surgeons in Ireland;
Orla Sherlock, PhD, Royal College of Surgeons in Ireland;
Deirdre Fitzgerald-Hughes, PhD, Royal College of Surgeons in Ireland;
Anna Shore, PhD, School of Dental Science and Dublin Dental Hospital, TCD;
Derek Sullivan, PhD, School of Dental Science and Dublin Dental Hospital, TCD;
Peter Kinnevey, School of Dental Science and Dublin Dental Hospital, TCD;
Angela S. Rossney, PhD, National MRSA Reference Laboratory;
Piaras O'Lorcain, PhD, Health Protection Surveillance Centre;
Robert Cunney, MD, Health Protection Surveillance Centre;
David Coleman, PhD, School of Dental Science and Dublin Dental Hospital, TCD;
Hilary Humphreys, MB, MRCPath, Royal College of Surgeons in Ireland
509
Should Universal Surveillance for Methicillin-resistant Staphylococcus aureus (MRSA) Be Performed in Neonatal Units?
Rachel R. Bailey, MPH, University of Pittsburgh;
Paul J. Ufberg, DO, MBA, University of Pittsburgh;
Kenneth J. Smith, MD, MS, University of Pittsburgh;
Robert Muder, MD, VA Pittsburgh Healthcare Sys;
Jared Feura, University of Pittsburgh;
Conor Higgins, University of Pittsburgh;
Andrew J. Nowalk, MD, PhD, Children's Hospital of Pittsburgh;
Bruce Y. Lee, MD, MBA, University of Pittsburgh
510
MRSA Prevention and Control Program in King Fahad Medical City
Sameeh Ghazal, MD, MRCPCH, King Fahad Medical City;
Syam Clara Viorica, MD, King Fahad Medical City;
Ahmed Hakawi, MD, King Fahad Medical City;
Mercy Joseph, RN, CIC, King Fahad Medical City;
Mohamod Mukahal, RN, KFMC
511
Cost-Effectiveness of Universal MRSA Screening on Admission to Surgery
Anant Murthy, MSc, Johns Hopkins Bloomberg School of Public Health;
Giulia De Angelis, MD, Geneva University Hospitals;
Didier Pittet, Geneva University Hospitals;
Jacques Schrenzel, MD, Geneva University Hospitals;
Ilker Uckay, Geneva University Hospitals;
Stephan Harbarth, MD, Geneva University Hospitals
512
Provider and Patient Perceptions on MRSA Prevention in Spinal Cord Injury Centers
Charlesnika Evans, PhD, MPH, Department of Veterans Affairs;
Jennifer Hill, Department of Veterans Affairs;
Kenzie Cameron, PhD, MPH, Northwestern University;
Kathleen Risa, Department of Veterans Affairs;
Michael Richardson, Department of Veterans Affairs;
Phoebe Doruelo, Department of Veterans Affairs;
Barry Goldstein, Department of Veterans Affairs;
Marylou Guihan, Department of Veterans Affairs
513
The impact of active surveillance in the reduction of HA-MRSA infections in a tertiary acute care hospital in Singapore
Moi Lin Ling, MBBS, FRCPA, Singapore General Hospital;
Kwee Yuen Tan, BSc, Singapore General Hospital;
Kue Bien How, BSc, Singapore General Hospital;
Asok Kurup, MBBS, MMed, Singapore General Hospital
514
Active Surveillance for MRSA in the Emergency Department of a Community Hospital
Joanne Levin, MD, Cooley Dickinson Hosp;
Linda Riley, RN, MEd, CIC, Cooley Dickinson Hosp;
Christine Parrish, MS, MSN, RN, CIC, Cooley Dickinson Hospital
515
MRSA Colonization Among At-Risk Surgical Patients in a Large Community Hospital System
Julia Moody, MS, SM, (ASCP), Hospital Corporation of America;
Edward Septimus, MD, Hospital Corporation of America;
Jane Englebright, RN, PhD, Hospital Corporation of America;
Stephanie Davis, RN, MSHA, Hospital Corporation of America;
Jason Hickok, RN, MBA, Hospital Corporation of America;
Jonathan Perlin, MD, PhD, Hospital Corporation of America
517
Comparison of Health Outcomes and Nephrotoxicity for Diabetic and Non-Diabetic Patients Hospitalized for MRSA Bacteremia
Nicolas A. Forcade, PharmD, The University of Texas at Austin and The University of Texas Health Science Center at San Antonio;
Ronald G. Hall, PharmD, BCPS, Texas Tech University Health Science Center and the Dallas Veterans Affairs Medical Center;
Sara D. Brouse, PharmD, Texas Tech University Health Science Center and the Dallas Veterans Affairs Medical Center;
Christopher Giuliano, Texas Tech University Health Science Center;
Kathleen Hazelwood, PharmD, The University of Wyoming School of Pharmacy;
Krystal Haase,, Texas Tech University Health Science Center;
Christopher R. Frei, The University of Texas at Austin and The University of Texas Health Science Center at San Antonio
518
The Association between Organizational Culture and Knowledge, Attitudes, and Practices in a Multicenter VA Quality Improvement Initiative to Prevent MRSA
Ronda Sinkowitz-Cochran, MPH, Centers for Disease Control and Prevention;
Kelly Burkitt, PhD, Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System;
Timothy Cuerdon, PhD, Office of Quality and Performance, US Department of Veterans Affairs;
Cassandra Harrison, BA, Centers for Disease Control and Prevention;
Shasha Gao, PhD, Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System;
D. Scott Obrosky, MS, Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System;
Rajiv Jain, MD, VA Pittsburgh Healthcare System;
Michael Fine, MD, MSc, Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System;
John Jernigan, MD, MS, Centers for Disease Control and Prevention
521
Improving efficiency in active surveillance for Methicillin-Resistant Staphylococcus aureus or Vancomycin-resistant Enterococcus at hospital admission
Daniel J. Morgan, Univ of Maryland;
Hannah R. Day, MS, University of Maryland;
Atlisa Young, MSW, University of Maryland;
Douglas D. Bradham, DrPH, University of Kansas, School of Medicine;
Eli N. Perencevich, MD, University of Maryland School of Medicine
522
Methicillin-Resistant Staphylococcus aureus (MRSA) Genomic Pattern: Temporal Changes in an Endemic Hospital Environment
Gleice Cristina Leite, MD, Faculdade de Ciências Médicas, Universidade Estadual de Campinas;
Maria Clara Padoveze, RN, MD, PhD, Escola de Enfermagem, Universidade de Sao Paulo;
Maria Luiza Moretti, MD, PhD, Faculdade de Ciências Médicas, Universidade Estadual de Campinas
523
Assessing the Efficacy of Hand Hygiene & Contact Precaution Adherence Rates on Nosocomial MRSA Transmission given Staffing and Behavioral Constraints within a Surgical Intensive Care Unit
Joc Cing Tay, PhD, ROSS Scientific Pte Ltd;
Zaiyi Guo, BEng, ROSS Scientific Pte Ltd;
Hardiyanto Wibisono, MSc, ROSS Scientific Pte Ltd;
Wei Boon Chan, BEng, ROSS Scientific Pte Ltd;
Paul Tambyah, MD, National University of Singapore
525
Prevalence of Staphylococcus aureus in Parturient Women
Matias C. Salomao, Hospital das Clinicas of University of Sao Paulo;
Cilmara P. Garcia, Hospital das Clinicas of University of Sao Paulo;
Renata D. Lobo, Hospital das Clinicas of University of Sao Paulo;
Satiko Gobara, Hospital das Clinicas of University of Sao Paulo;
Kleiste G. Keil, Hospital das Clinicas of University of Sao Paulo;
Carla H. Mollaco, Hospital das Clinicas of University of Sao Paulo;
Maria Augusta B. C. Gibelli, Hospital das Clinicas of University of Sao Paulo;
Vera L. J. Krebs, Hospital das Clinicas of University of Sao Paulo;
Mario M. Kondo, Hospital das Clinicas of University of Sao Paulo;
Marcelo Zugaib, Hospital das Clinicas of University of Sao Paulo;
Silvia F. Costa, Hospital das Clinicas of University of Sao Paulo;
Juliana R. Ferraz, Hospital das Clinicas of University of Sao Paulo;
Robson E. Soares, Hospital das Clinicas of University of Sao Paulo;
Maria Aparecida Cursino, Hospital das Clinicas of University of Sao Paulo;
Anna S. Levin, Hospital das Clinicas of University of Sao Paulo
526
Risk Factors for Healthcare-Associated Community-Onset Invasive Methicillin-Resistant Staphylococcus aureus Infections
Jonathan Duffy, MD, MPH, CDC;
Brian Kit, MD, CDC;
Ghinwa Dumyati, MD, University of Rochester;
Sandra Bulens, MPH, CDC;
Swathi Namburi, CDC;
Anita Gellert, RN, Rochester General Hospital;
Scott Fridkin, MD, CDC;
Fernanda Lessa, MD, MPH, CDC
529
Dramatic Reduction in Rates of Methicillin-Resistant Staphylococcus Aureus (MRSA) Following Introduction of a Hand Hygiene Initiative
Penelope Radalj, RN, Barwon Health;
Jill Low, RN, Barwon Health;
Kaylene Styles, RN, Barwon Health;
Ann Gray, RN, Barwon Health;
Owen Harris, MBBS, FRCPA, Saint John of God Pathology, Pathcare;
N. Deborah Friedman, MBBS, FRACP, MD, Barwon Health
530
Failure of the rate of nosocomial MRSA infections to decline with decreasing MRSA transmissions during universal screening
John A. Sellick, DO, University at Buffalo/SUNY;
Karen Schoenhals, RN, Buffalo DVAMC;
Elaine Watson, RN, CIC, Buffalo DVAMC;
Linda Robitaille, RN, CIC, Buffalo DVAMC
532
Implementation of Universal Screening on a National Scale
Sally Stewart, MSc, NHS Health Protection Scotland;
Jacqui Reilly, NHS Health Protection Scotland;
Gwen Allardice, PhD, NHS Health Protection Scotland;
Smith Ann, MPH, NHS Health Protection Scotland;
Ian Gould, MD, Grampian Health Board;
Robert Masterton, MD, Ayrshire and Arran Health Board;
Craig Williams, MD, Greater Glasgow and Clyde Health Board
533
Surveillance of Staphylococcus aureus Bacteraemias by Specialty in Wales: Trends over Time
Mari Morgan, Welsh Healthcare Associated Infection Programme, Public Health Wales NHS Trust;
Victoria McClure, Welsh Healthcare Associated Infection Programme, Public Health Wales NHS Trust;
Susan Harris, Welsh Healthcare Associated Infection Programme, Public Health Wales NHS Trust;
Eleri Davies, Welsh Healthcare Associated Infection Programme, Public Health Wales NHS Trust
536
Model-Based Cost-Effectiveness Evaluation of Screening and Isolation Strategies in the Control of Methicillin-Resistant Staphylococcus aureus
Julie V. Robotham, PhD, Health Protection Agency;
Nicholas Graves, PhD, Queensland University of Technology;
Barry D. Cookson, FRCPath, FRCP, Health Protection Agency;
Jennie Wilson, MSc, Health Protection Agency;
Adrian G. Barnett, PhD, Institute of Health and Biomedical Innovation & School of Public Health, Queensland University of Technology;
Jonathan Edgeworth, PhD, MRCP, FRCPat, Guy's and St Thomas' Hospital Foundation Trust;
Rahul Batra, MD, Guy's and St Thomas' Hospital Foundation Trust;
Ben S. Cooper, BSc, MSc, PhD, Mahidol University Tropical Medicine Research Unit
537
Epidemiology and outcomes of hospitalizations with MRSA vs MSSA or MRSA+MSSA complicated skin and skin structure infections
Marya Zilberberg, MD, MPH, EviMed Research Group, LLC;
Smita Kothari, PhD, MBA, Astellas Pharma US, Inc;
Rebecca S. Campbell, MD, MPH, Cerner Corporation;
Matthew F. Emons, MD, MBA, Cerner Corporation;
Suzanne Fiske, MS, Cerner Corporation;
Harlen D. Hays, MPH, Cerner Corporation;
Andrew Shorr, MD, MPH, Washington Health Center
538
Hand Acquisition of Methicillin-Resistant Staphylococcus aureus After Contact With Environmental Surfaces Versus Skin of Colonized Patients
Usha Stiefel, MD, Cleveland VA Medical Center;
Jennifer L. Cadnum, BSc, Cleveland VA Medical Center;
Brittany C. Eckstein, BA, Cleveland VA Medical Center;
Dubert Guerrero, MD, University Hospitals of Cleveland/Case Medical Center;
Mary Ann Tima, BSc, Cleveland VA Medical Center;
Curtis J. Donskey, MD, Cleveland VA Medical Center
539
Surveillance of mupirocin susceptibility in MRSA over a 10-year period in a tertiary care hospital
Dominique S. Blanc, PhD, Hospital Preventive Medicine Service, Centre hospitalier Universitaire Vaudois and University of Lausanne;
Laurence Senn, MD, Hospital Preventive Medicine Service, Centre hospitalier Universitaire Vaudois and University of Lausanne;
Immaculée Nahimana, MD, Hospital Preventive Medicine Service, Centre hospitalier Universitaire Vaudois and University of Lausanne;
Valérie Vogel, PhD, Hospital Preventive Medicine Service, Centre hospitalier Universitaire Vaudois and University of Lausanne;
Patrick Basset, PhD, Hospital Preventive Medicine Service, Centre hospitalier Universitaire Vaudois and University of Lausanne;
Giorgio Zanetti, MD, MS, Hospital Preventive Medicine Service, Centre hospitalier Universitaire Vaudois and University of Lausanne
541
Methicillin-resistant Staphylococcus aureus among hospitalized pediatric patients in Canadian acute care facilities 1995-2007
Anne G. Matlow, MD, MSc, Hospital for Sick Children;
Linda Pelude, MSc, Public Health Agency of Canada;
Sarah E. Forgie, MD, Stollery Childrens Hospital;
Dorothy L. Moore, MD, PhD, Montreal Children's Hospital;
Denise Gravel, MSc, Public Health Agency of Canada;
Michael Mulvey, PhD, National Microbiology Lab Public Health Agency of Canada;
Joseph Vayalumkal, MD, Alberta Children's Hospital;
Joanne Embree, MD, Winnipeg Children's Hospital;
Joanne M. Langley, MD, Dalhousie University;
Nicole Le Saux, MD, Children's Hospital of Eastern Ontario;
Karen Olekson, RN, CIC, Winnipeg Children's Hospital;
Susan J. Gilbride, RN, CIC, Stollery Childrens Hospital;
Sally Strople, RN, CIC, Alberta Children's Hospital;
Yasmine Chagla, MSc, London Health Services Center;
Andrew E. Simor, MD, Sunnybrook Health Science Center
543
Impact of an MRSA Outbreak on Hospital Costs
Matthew Paul Muller, MD, PhD, FRCPC, St. Michael's Hospital, University of Toronto;
Depeng Jiang, PhD, Li Ka Shing Knowledge Institute, St. Michael's Hospital;
Tharsiya Nagulesapillai, BSc, Li Ka Shing Knowledge Institute, St. Michael's Hospital;
Magda Melo, MSc, Li Ka Shing Knowledge Institute, St. Michael's Hospital;
Muhammad Mamdani, MPH, MA, PharmD, Li Ka Shing Knowledge Institute, St. Michael's Hospital
544
Factors associated with Inappropriate Definitive Antimicrobial Therapy for Bloodstream Infection (BSI) Due to Methicillin-Resistant Staphylococcus aureus (MRSA)
Carrie A. Herzke, MD, Johns Hopkins Medical Institute;
Keith Kaye, MD, MPH, University Health Center;
Deverick J. Anderson, MD, MPH, Duke University Medical Center;
Yong Il Choi, MSN, Duke University Medical Center;
Daniel J. Sexton, MD, FACP, Duke University Medical Center;
Luke F. Chen, MBBS, FRACP, Duke University Medical Center
545
Multistate Modelling to Estimate the Excess Length of Stay Associated with MRSA Infection in Surgical Patients
Giulia De Angelis, MD, Geneva University Hospitals;
Arthur Allignol, MSc, Freiburg centre for Data Analysis and Modelling, University of Freiburg;
Anant Murthy, MSc, Johns Hopkins Bloomberg School of Public Health;
Martin Wolkewitz, PhD, Freiburg centre for Data Analysis and Modelling, University of Freiburg;
Jan Beyersmann, PhD, Freiburg centre for Data Analysis and Modelling, University of Freiburg;
Edith Safran, MD, Geneva University Hospitals;
Jacques Schrenzel, MD, Geneva University Hospitals;
Didier Pittet, MD, MS, Geneva University Hospitals;
Stephan Harbarth, MD, MS, Geneva University Hospitals
546
Impact of the VA MRSA [methicillin-resistant Staphylococcus aureus] Initiative on the Incidence of Nosocomial MRSA Infection in Intensive Care Units at the Minneapolis VA Medical Center
Joseph R. Thurn, M.P.H, M.D., Minneapolis VA Medical Center and University of Minnesota;
Kristina Scott, R.N., B.S.N., Minneapolis VA Medical Center;
Laurel Chelstrom, R.N., M.P.H., Minneapolis VA Medical Center;
Kent Crossley, M.D., Minneapolis VA Medical Center
547
Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection among hospitalized patients with nasal MRSA colonization
Brendan M. De Marco, MD, MPH, UT Southwestern Medical Center;
Anthony Ortegon, MD, UT Southwestern Medical Center;
Vivek Ramarathnam, MD, UT Southwestern Medical Center;
Abidemi Ayeni, MBBS, MPH, UT Southwestern Medical Center;
Dale Kemp, LVN, Parkland Health and Hospital System;
James Luby, MD, UT Southwestern Medical Center;
Pranavi Sreeramoju, MD, MPH, UT Southwestern Medical Center
548
Universal MRSA Screening to Assess Colonization Results in Sustainable Eradication of Hospital-Associated MRSA in a Tertiary Care NICU
Susan A. Dolan, RN, MS, CIC, The Children's Hospital;
Sheila Kaseman, RN, MS, The Children's Hospital;
Michelle Mueller, RN, BSN, The Children's Hospital;
Patricia Boldt, RN, BSN, The Children's Hospital;
Kristen Hampton, RNC, BSN, The Children's Hospital;
Theresa Grover, MD, The Children's Hospital;
Ann-Christine Nyquist, MD, MSPH, The Children's Hospital
549
The Economic Impact of Antimicrobial Resistance in Patients with Nosocomial Staphylococcus aureus Bacteremia
Suzanne T. Phillips, PharmD, MPH, PhD, Evans Army Community Hospital;
Ronald Polk, PharmD, Virginia Commonwealth University;
Spencer E. Harpe, PharmD, MPH, PhD, Virginia Commonwealth University;
Amy Pakyz, Virginia Commonwealth University;
Michael Edmond, MD, MPH, MPA, Virginia Commonwealth University Medical Center;
Norman V. Carroll, PhD, Virginia Commonwealth University;
Elizabeth E. Turf, PhD, Virginia Commonwealth University
550
Economic Impact of Pre-Operative Screening and Decolonization of Orthopedic Surgery Patients for Methicillin-resistant Staphylococcus aureus (MRSA)
Ann E. Wiringa, University of Pittsburgh;
Vishal Goyal, University of Pittsburgh;
Rachel R. Bailey, MPH, University of Pittsburgh;
Becky Y. Tsui, MPH, University of Pittsburgh;
G. Jonathan Lewis, DO, MPH, University of Pittsburgh;
Kenneth J. Smith, MD, MS, University of Pittsburgh;
Robert R. Muder, MD, VA Pittsburgh Healthcare Sys;
Lee H. Harrison, MD, University of Pittsburgh;
Bruce Y. Lee, MD, MBA, University of Pittsburgh
551
Hospital Associated Infections Due to MRSA and Other Multiply Resistant Organisms After a Hospital-Wide MRSA Control Program: 4 Year Follow-up
Robert R. Muder, MD, VA Pittsburgh Healthcare Sys;
Cheryl Squier, RN, VA Pittsburgh Healthcare Sys;
Candace Cunningham, RN, VA Pittsburgh Healthcare Sys;
Laura Morris, BS, VA Pittsburgh Healthcare Sys;
Rajiv Jain, MD, VA Pittsburgh Healthcare Sys
552
Reduction of Methicillin- Resistant Staphylococcus aureus (MRSA) Health Care Associated Infections in Two Spinal Cord Injury Units Using the VHA MRSA Bundle- A Two Year Perspective
Patricia A. Byers, BS, M(ASCP), CIC, Michael E. DeBakey Veterans Affairs Medical Center;
Rosetta P. Thompson, RN, Michael E. DeBakey Veterans Affairs Medical Center;
Serena Starns, Michael E. DeBakey Veterans Affairs Medical Center;
Debra A. Lewis, MS, RN, Michael E. DeBakey Veterans Affairs Medical Center;
Edward J. Young, MD, Michael E. DeBakey Veterans Affairs Medical Center
553
Hospital-Acquired Pneumonia (HAP) caused by Staphylococcus aureus (SA): Treatment, Resource Use, and Mortality
rebecca S. Campbell, MD, MPH, Cerner Corporation;
Anthony Harris, MD, MPH, University of Maryland School of Medicine;
Andrew A. Kramer, PhD, Cerner Corporation;
Smita Kothari, PhD, MBA, Astellas Pharma US, Inc;
Suzanne Fiske, MS, Cerner Corporation;
Harlen D. Hays, MPH, Cerner Corporation;
Randall K. Spoeri, PhD, Cerner Corporation;
Matthew F. Emons, MD, MBA, Cerner Corporation
554
Patient-associated Risk Factors for Acquisition of Methicillin Resistant Staphylococcus aureus (MRSA) in a Tertiary Hospital Setting
Jo-anne M. Salangsang, MD, MS, University of Pittsburgh Medical Center;
Lee H. Harrison, MD, University of Pittsburgh Medical Center;
Maria M. Brooks, PhD, University of Pittsburgh;
Kathleen A. Shutt, MS, University of Pittsburgh;
Melissa I. Saul, MS, University of Pittsburgh;
Carlene A. Muto, MD, MS, University of Pittsburgh Medical Center
555
Comparison of Automated and Manual Methods of Estimating Methicillin-Resistant Staphylococcus aureus (MRSA) Healthcare-Associated Infection (HAI) Rates
Makoto Jones, MD, University of Utah School of Medicine;
Matthew Samore, MD, IDEAS Center;
Molly Leecaster, PhD, University of Utah School of Medicine;
Patricia Nechodom, MPH, University of Utah School of Medicine;
Susan O'Connor-Wright, RN, MS, CIC, VA Salt Lake City Health Care System;
Michael Rubin, MD, PhD, IDEAS Center
557
Vancomycin minimal inhibitory concentration and outcomes of MRSA bacteremia
Hee-Chang Jang, M.D., Seoul National University, College of Medicine;
Koung Ho Song, Seoul National University, College of Medicine;
Wan Beom Park, Seoul National University, College of Medicine;
Eu Suk Kim, MD, Department of Infectious Diseases, Dongguk University International Hospital;
Hong Bin Kim, MD, PhD, Seoul National University Bundang Hospital;
Nam Joong Kim, Seoul National University, College of Medicine;
Eui-Chong Kim, MD, PhD, Department of Laboratory Medicine, Seoul National University Hospital;
Myoung-don Oh, Seoul National University, College of Medicine
559
Cost-Effectiveness of Adding De-colonization to a Surveillance Strategy of Screen and Isolation for Hospital Acquired MRSA Infections
Richard E. Nelson, PhD, Division of Epidemiology, University of Utah;
Matthew Samore, MD, Division of Epidemiology, University of Utah;
Michael Rubin, MD, PhD, Division of Epidemiology, University of Utah
560
Risk factors and Outcome of Infections Caused by Methicillin-Resistant Staphylococcus aureus (MRSA) in Lebanon
Mohamad Yasmine, MD, American University of Beirut Medical Center;
Salma Jabak, BS, American University of Beirut Medical Center;
Tania Baban, MD, American University of Beirut Medical Center;
Nisreen Sidani, MSN, American University of Beirut Medical Center;
Souha Kanj, MD, American University of Beirut Medical Center;
George Araj, PhD, American University of Beirut Medical Center;
Zeina Kanafani, American University of Beirut Medical Center
561
Eight-Year Surveillance, Genotyping and Strain-Relatedness of Nosocomial Methicillin-Resistant Staphylococcus aureus (MRSA) at Intermountain Healthcare Hospitals in Salt Lake City, Utah
David J. Pombo, MD, Intermountain Medical Center;
Rajesh Mehta, RPh, MS, LDS Hospital;
Sharon Sumner, RN, Intermountain Medical Center;
Ruth Kleckner, RN, Intermountain Medical Center;
Caroline Taylor, RN, CIC, Intermountain Medical Center;
Vickie Anderson, RN, Intermountain Medical Center;
Tom Trego, MS, Intermountain Healthcare;
John P. Burke, MD, Intermountain Medical Center
![[ Visit the Fifth Decennial online ]](images/banner.gif)